Ottawa, ON
Genome Canada has named Dalia Morcos Fraser as Vice-President, Corporate Services and Chief Financial Officer. Ms. Morcos Fraser’s extensive knowledge of the health research ecosystem—combined with her financial acumen and executive management skills—equip her to provide strategic vision and direction to Genome Canada to strengthen its corporate foundation, advance its ability to do challenge-driven science, and deepen its commitment to equity, diversity and inclusion (EDI).
“I am so excited to welcome Dalia to Genome Canada. She brings a wealth of experience, expertise and passion, and will be a valued member of the executive team and an incredible leader of the organization. We are deeply impressed with her commitment to inclusion, diversity, equity and accessibility, as well as to living the values described in our Playbook. We are thrilled Dalia has chosen to join Team Genome Canada!”
—Dr. Rob Annan, President and CEO, Genome Canada
Ms. Morcos Fraser brings years of executive leadership experience in health research to her role. Most recently, she was Chief Financial Officer of the Canadian Institutes of Health Research (CIHR), where she oversaw a $1.2 billion budget and all aspects of the organization’s financial management. This included advising the President on key aspects of operations, controls and financial stewardship and overseeing financial planning, reporting, operations and systems along with grants and awards, procurement and facilities management.
This position will build on Ms. Morcos Fraser’s financial leadership and relationship management skills. At CIHR, she spearheaded the development of a rigorous financial management framework and played a key role in maturing the organization’s resource management strategies. She was also a key liaison with central agencies and stakeholders and played a vital role in ensuring alignment and support for CIHR’s operations.
Ms. Morcos Fraser is a long-time advocate and champion of EDI in the workplace and brings a commitment to these values to all aspects of her work. As Champion and Chair of CIHR’s EDI committee, she promoted engagement across the organization to create a more diverse, inclusive workforce, and encouraged other employees to embed EDI in all aspects of their work.
“I am thrilled to be joining the Genome Canada family because I believe in the challenge-driven approach to its work. I plan to strengthen the corporate foundation to embed equity, diversity and inclusion in our culture and practices because that will make us stronger, more productive and truly reflective of the communities we serve. I am inspired by the potential research impacts built on the vision of an equitable, diverse and inclusive application of genomics. This is the foundation we need for real impact.”
—Dalia Morcos Fraser, Vice-President, Corporate Services and Chief Financial Officer, Genome Canada
Read Ms. Morcos Fraser’s full bio.
-30-
About Genome Canada
Genome Canada is a national not-for-profit organization addressing Canada’s greatest challenges and opportunities through research and innovation in genomics and associated biosciences. With a 21-year track record of impact across sectors, a pan-Canadian network of six regional Genome Centres, and strong partnerships across the public, private, non-profit and academic sectors at home and internationally, we translate research into real-world impact in health, climate action and food security.
